• Product
  • RSNA 2025
  • About
  • News & Research
  • Contact
  • Product
  • RSNA 2025
  • About
  • News & Research
  • Contact
Join the Waitlist

News

Clairity Unites Pioneers In Medicine And Technology To Redefine Predictive AI For Human Health

December 3, 2025 by Fresh

Clairity, developer of the first image-only AI model authorized by the U.S. Food and Drug Administration (FDA) that estimates a woman’s …

Read moreClairity Unites Pioneers In Medicine And Technology To Redefine Predictive AI For Human Health

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

November 13, 2025 by Fresh

Clairity, Inc., an AI-driven precision health company pioneering image-based risk prediction, today announced the closing of a $43 …

Read moreClairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

Clairity Showcases Demonstration of CLAIRITY BREAST on NBC’s TODAY Show

October 26, 2025 by Fresh

During the broadcast, Dr. Connie Lehman shared a five-year breast cancer risk estimate for NBC anchor Savannah Sellers, generated from …

Read moreClairity Showcases Demonstration of CLAIRITY BREAST on NBC’s TODAY Show

Clairity Founder Dr. Connie Lehman Named to Forbes 50 Over 50 Innovation List

October 16, 2025 by Fresh

Clairity, Inc., a company pioneering AI-powered risk prediction in human health, today announced that Founder Dr. Connie Lehman has been …

Read moreClairity Founder Dr. Connie Lehman Named to Forbes 50 Over 50 Innovation List

Clairity to Spotlight Groundbreaking AI Research in Breast Cancer Risk Prediction at RSNA 2025

October 14, 2025 by Fresh

Clairity Inc., a leader in AI-based breast cancer risk prediction, today announced that five scientific presentations featuring its …

Read moreClairity to Spotlight Groundbreaking AI Research in Breast Cancer Risk Prediction at RSNA 2025

Clairity CEO, Jeff Luber, Presenting at BIO International Convention 2025

June 12, 2025 by justin

BOSTON--(BUSINESS WIRE)--Clairity, Inc., advancing AI-powered human health solutions, today announced that members of its executive …

Read moreClairity CEO, Jeff Luber, Presenting at BIO International Convention 2025

Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health

June 2, 2025 by justin

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration …

Read moreClairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health

The Breast Cancer Research Foundation Backs Clairity’s AI-Based Risk Assessment

May 30, 2025 by justin

Clairity, Inc. is proud to announce a $1M investment from the Breast Cancer Research Foundation (BCRF) in support of Clairity, a leading …

Read moreThe Breast Cancer Research Foundation Backs Clairity’s AI-Based Risk Assessment

Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion

May 30, 2025 by justin

Clairity, Inc., a pioneer in AI-based predictive tools for breast cancer, is pleased to announce the appointment of Jeffrey R. Luber, …

Read moreClairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion

How an AI Scientist Turned Her Breast Cancer Diagnosis Into a Tool to Save Lives

November 9, 2021 by taylor

The development of an AI-based system for early detection of breast cancer has the ability to predict whether a patient is likely to …

Read moreHow an AI Scientist Turned Her Breast Cancer Diagnosis Into a Tool to Save Lives
  • Page 1
  • Page 2
  • Next
  • Research
  • About
  • Careers
  • Contact
  • Research
  • About
  • Careers
  • Contact
  • Research
  • About
  • Careers
  • Contact
  • Research
  • About
  • Careers
  • Contact

Privacy Policy | © 2026 Clairity™

Clairity, Inc. | 361 Newbury Street, Suite 402, Boston, MA 02115